Literature DB >> 15907830

Relationship between serum butyrylcholinesterase and the metabolic syndrome.

Edward W Randell1, Maria S Mathews, Hongwei Zhang, Jim S Seraj, Guang Sun.   

Abstract

OBJECTIVE: To identify independent predictors of serum butyrylcholinesterase (BuChE) activity and examine its relationship with the metabolic syndrome. DESIGN AND METHODS: Serum BuChE activity was measured and metabolic syndrome risk factors were assessed in 1097 healthy subjects recruited from the Newfoundland adult population.
RESULTS: Serum BuChE activity was related to insulin homeostasis and correlated with fasting insulin levels (r = 0.266, P < 0.001) and insulin resistance (HOMA-R) index (r = 0.292, P < 0.001) and was higher in individuals with risk factors for the metabolic syndrome. BuChE activity was higher in males than in females and correlated most strongly with serum triglyceride levels (r = 0.363, P < 0.001) and indicators of abdominal obesity (r = 0.355, P < 0.001). Percent trunk fat (beta = 0.185, P < 0.001), triglyceride levels (beta = 0.225, P < 0.001), sex (beta = -0.202, P = 0.001), glucose (beta = 0.209, P < 0.001), insulin (beta = 0.360, P = 0.011), HOMA-R (beta = -0.319, P = 0.044), and age (beta = 0.086, P = 0.002) were independent predictors of BuChE activity.
CONCLUSIONS: These results suggest the involvement of BuChE in the pathophysiological process constituting the metabolic syndrome. Whether increased BuChE activity precedes or follows the development of risk factors is not known.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907830     DOI: 10.1016/j.clinbiochem.2005.04.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  22 in total

1.  Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.

Authors:  G R Sridhar; G Nirmala; Allam Apparao; A S Madhavi; S Sreelatha; J Sudha Rani; P Vijayalakshmi
Journal:  Lipids Health Dis       Date:  2005-09-08       Impact factor: 3.876

Review 2.  Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.

Authors:  Gohar Mushtaq; Nigel H Greig; Jalaluddin A Khan; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

3.  GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.

Authors:  Beben Benyamin; Rita P Middelberg; Penelope A Lind; Anne M Valle; Scott Gordon; Dale R Nyholt; Sarah E Medland; Anjali K Henders; Andrew C Heath; Pamela A F Madden; Peter M Visscher; Daniel T O'Connor; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-08-23       Impact factor: 6.150

4.  Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Michael B Stout; Michael D Jensen; Stephen Brimijoin
Journal:  Endocrinology       Date:  2016-06-14       Impact factor: 4.736

5.  aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.

Authors:  A T Isik; E Bozoglu; D Eker
Journal:  J Nutr Health Aging       Date:  2012-02       Impact factor: 4.075

6.  The Correlative Study of Serum Pseudo-cholinesterase, Biological Parameters and Symptoms Among Occupational Workers.

Authors:  Tanasorn Tunsaringkarn; Kalaya Zapuang; Anusorn Rungsiyothin
Journal:  Indian J Clin Biochem       Date:  2013-04-03

7.  Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.

Authors:  Asad Vaisi-Raygani; Zohreh Rahimi; Haidar Tavilani; Tayebeh Pourmotabbed
Journal:  Mol Biol Rep       Date:  2009-08-15       Impact factor: 2.316

8.  Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index.

Authors:  Karine S De Bona; Gabriela Bonfanti; Paula E R Bitencourt; Lariane O Cargnelutti; Priscila S da Silva; Leidiane De Lucca; Victor C Pimentel; Etiane Tatsch; Thissiane L Gonçalves; Melissa Premaor; Rafael N Moresco; Maria Beatriz Moretto
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

9.  Butyrylcholinesterase gene transfer in obese mice prevents postdieting body weight rebound by suppressing ghrelin signaling.

Authors:  Vicky Ping Chen; Yang Gao; Liyi Geng; Stephen Brimijoin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

Review 10.  Ghrelin and liver disease.

Authors:  Mar Quiñones; Johan Fernø; Omar Al-Massadi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.